Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling
暂无分享,去创建一个
Gabriele Schackert | Andreas von Deimling | Markus Loeffler | Hans Binder | Bernhard Radlwimmer | Michael Weller | Christian Hartmann | Wolfgang Wick | Jakob Matschke | Torsten Pietsch | Manfred Westphal | Guido Reifenberger | Bettina Hentschel | Henry Wirth | G. Reifenberger | M. Weller | H. Binder | J. Schramm | M. Loeffler | A. von Deimling | M. Westphal | W. Wick | G. Schackert | C. Hartmann | U. Schlegel | J. Steinbach | T. Pietsch | B. Hentschel | H. Wirth | B. Radlwimmer | E. Willscher | J. Matschke | M. Sabel | J. Felsberg | K. Kaulich | M. Simon | Johannes Schramm | Jörg Felsberg | Kerstin Kaulich | Uwe Schlegel | Matthias Simon | Joachim P Steinbach | R. Weber | Edith Willscher | V. Riehmer | Jörg C Tonn | Vera Riehmer | Dorothee Gramatzki | Ruthild G Weber | Jens Gietzelt | Michael C Sabel | D. Gramatzki | J. Tonn | Jens Gietzelt | M. Simon | M. Simon
[1] E. Helseth,et al. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme. , 2012, Neuro-oncology.
[2] R. Wilson,et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. , 2010, Cancer cell.
[3] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[4] T. Golub,et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.
[5] David E. Misek,et al. Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. , 2003, The American journal of pathology.
[6] Andrey Korshunov,et al. Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.
[7] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[8] B. O'neill,et al. Glioblastoma survival in the United States before and during the temozolomide era , 2012, Journal of Neuro-Oncology.
[9] Walter J Curran,et al. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Martin von Bergen,et al. Expression cartography of human tissues using self organizing maps , 2011, BMC Bioinformatics.
[11] M. Wolter,et al. Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing , 2010, Acta Neuropathologica.
[12] Gabriele Schackert,et al. Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.
[13] P. Lichter,et al. Detection of chromosomal imbalances in retinoblastoma by matrix‐based comparative genomic hybridization , 2005, Genes, chromosomes & cancer.
[14] F. Ducray,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[15] Pablo R. Freire,et al. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. , 2013, Neuro-oncology.
[16] R. Fimmers,et al. Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients , 2009, Clinical Cancer Research.
[17] G. Reifenberger,et al. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] David T. W. Jones,et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.
[19] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[20] P. Kleihues,et al. The Definition of Primary and Secondary Glioblastoma , 2012, Clinical Cancer Research.
[21] G. Reifenberger,et al. Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations , 2013, Clinical Cancer Research.
[22] D. Haussler,et al. The Somatic Genomic Landscape of Glioblastoma , 2013, Cell.
[23] Christian Mawrin,et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas , 2009, Acta Neuropathologica.
[24] M. Wolter,et al. Molecular signatures classify astrocytic gliomas by IDH1 mutation status , 2011, International journal of cancer.
[25] M Loeffler,et al. Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization , 2007, Methods of Information in Medicine.
[26] R. Mirimanoff,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[27] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[28] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[29] B. Kleinschmidt-DeMasters,et al. Increased Immune Gene Expression and Immune Cell Infiltration in High-Grade Astrocytoma Distinguish Long-Term from Short-Term Survivors , 2012, The Journal of Immunology.
[30] G. Reifenberger,et al. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. , 2011, Journal of the National Cancer Institute.
[31] K. Hoang-Xuan,et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Gabriele Schackert,et al. DNA methylation profiles of long- and short-term glioblastoma survivors , 2013, Epigenetics.